Clinical Trial Update: A Study of Envafolimab in Subjects With Stage III Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for Envafolimab in stage III non-small cell lung cancer is reported as ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Envafolimab (envafolimab)

Snippet

Sponsor: Anhui Provincial Cancer Hospital | Conditions: Non-small Cell Lung Cancer Stage III | Phase 2 | Status: UNKNOWN